Immunogenicity and immunoprotection of porcine circovirus type 2 (PCV2) Cap protein displayed by Lactococcus lactis

Vaccine

Volumn 34, Issue 5, 2016, Pages 696-702

  Li, Peng cheng ^a   Qiao, Xu wen ^a   Zheng, Qi sheng ^a   Hou, Ji bo ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

Cap protein; Lactococcus lactis; PCV2 subunit vaccine; Porcine circovirus type 2; Surface display

Indexed keywords

CAPSID PROTEIN; PHOSPHATE BUFFERED SALINE; SUBUNIT VACCINE; RECOMBINANT PROTEIN; VIRUS ANTIBODY; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CELL; CELL SURFACE; CONTROLLED STUDY; IMMUNIZATION; IMMUNOFLUORESCENCE; IMMUNOGENICITY; LACTOCOCCUS LACTIS; NONHUMAN; PIGLET; PORCINE CIRCOVIRUS 2; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; VACCINATION REACTION; VIRUS STRAIN; WEIGHT GAIN; WESTERN BLOTTING; WILD TYPE; ANIMAL; BLOOD; CIRCOVIRIDAE INFECTIONS; CIRCOVIRUS; HUMORAL IMMUNITY; IMMUNOLOGY; LUNG; PATHOLOGY; PIG; SWINE DISEASES; VETERINARY;

ANIMALS; ANTIBODIES, VIRAL; CAPSID PROTEINS; CIRCOVIRIDAE INFECTIONS; CIRCOVIRUS; IMMUNITY, HUMORAL; LACTOCOCCUS LACTIS; LUNG; RECOMBINANT PROTEINS; SWINE; SWINE DISEASES; VACCINES, SUBUNIT; VIRAL VACCINES;

EID: 84953836976     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.09.007     Document Type: Article

References (42)

1. Allan G.M., Ellis J.A. Porcine circoviruses: a review. J Vet Diagn Invest 2000, 12(January (1)):3-14.
2. Grau-Roma L., Fraile L., Segales J. Recent advances in the epidemiology, diagnosis and control of diseases caused by porcine circovirus type 2. Vet J 2011, 187(January (1)):23-32.
3. Rose N., Opriessnig T., Grasland B., Jestin A. Epidemiology and transmission of porcine circovirus type 2 (PCV2). Virus Res 2012, 164(March (1-2)):78-89.
4. O'Dea M.A., Kabay M.J., Carr J., Wilcox G.E., Richards R.B. Porcine circovirus-associated disease in weaner pigs in Western Australia. Aust Vet J 2011, 89(April (4)):122-130.
5. Ge X., Wang F., Guo X., Yang H. Porcine circovirus type 2 and its associated diseases in China. Virus Res 2012, 164(March (1-2)):100-106.
6. Opriessnig T., Langohr I. Current state of knowledge on porcine circovirus type 2-associated lesions. Vet Pathol 2013, 50(January (1)):23-38.
7. Opriessnig T., Gauger P.C., Faaberg K.S., Shen H., Beach N.M., Meng X.J., et al. Effect of porcine circovirus type 2a or 2b on infection kinetics and pathogenicity of two genetically divergent strains of porcine reproductive and respiratory syndrome virus in the conventional pig model. Vet Microbiol 2012, 158(July (1-2)):69-81.
8. Beach N.M., Meng X.J. Efficacy and future prospects of commercially available and experimental vaccines against porcine circovirus type 2 (PCV2). Virus Res 2012, 164(March (1-2)):33-42.
9. Lin H.X., Ma Z., Fan H.J., Lu C.P. Construction and immunogenicity of recombinant swinepox virus expressing capsid protein of PCV2. Vaccine 2012, 30(September (44)):6307-6313.
10. Zhu Y., Lau A., Lau J., Jia Q., Karuppannan A.K., Kwang J. Enhanced replication of porcine circovirus type 2 (PCV2) in a homogeneous subpopulation of PK15 cell line. Virology 2007, 369(December (2)):423-430.
11. Kuhler T.C., Andersson M., Carlin G., Johnsson A., Akerblom L. Do biological medicinal products pose a risk to the environment?: a current view on ecopharmacovigilance. Drug Saf 2009, 32(November (11)):995-1000.
12. Lee S.Y., Choi J.H., Xu Z. Microbial cell-surface display. Trends Biotechnol 2003, 21(January (1)):45-52.
13. Bosma T., Kanninga R., Neef J., Audouy S.A., van Roosmalen M.L., Steen A., et al. Novel surface display system for proteins on non-genetically modified gram-positive bacteria. Appl Environ Microbiol 2006, 72(January (1)):880-889.
14. Audouy S.A., van Selm S., van Roosmalen M.L., Post E., Kanninga R., Neef J., et al. Development of lactococcal GEM-based pneumococcal vaccines. Vaccine 2007, 25(March (13)):2497-2506.
15. Ramirez K., Ditamo Y., Rodriguez L., Picking W.L., van Roosmalen M.L., Leenhouts K., et al. Neonatal mucosal immunization with a non-living, non-genetically modified Lactococcus lactis vaccine carrier induces systemic and local Th1-type immunity and protects against lethal bacterial infection. Mucosal Immunol 2010, 3(March (2)):159-171.
16. van Roosmalen M.L., Kanninga R., El Khattabi M., Neef J., Audouy S., Bosma T., et al. Mucosal vaccine delivery of antigens tightly bound to an adjuvant particle made from food-grade bacteria. Methods 2006, 38(February (2)):144-149.
17. Zadravec P., Strukelj B., Berlec A. Improvement of LysM-mediated surface display of designed ankyrin repeat proteins (DARPins) in recombinant and nonrecombinant strains of Lactococcus lactis and Lactobacillus species. Appl Environ Microbiol 2015, 81(March (6)):2098-2106.
18. Ramasamy R., Yasawardena S., Zomer A., Venema G., Kok J., Leenhouts K. Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations. Vaccine 2006, 24(May (18)):3900-3908.
19. Meng X.J. Porcine circovirus type 2 (PCV2): pathogenesis and interaction with the immune system. Annu Rev Anim Biosci 2013, 1(January):43-64.
20. Silva J.G., Coimbra E.C., Jesus A.L., Mariz F.C., Silva K.M., Lobato Z.I., et al. Secretory expression of porcine circovirus type 2 capsid protein in Pichia pastoris. J Virol Methods 2014, 207(October):226-231.
21. Huang L., Lu Y., Wei Y., Guo L., Liu C. Development of a blocking ELISA for detection of serum neutralizing antibodies against porcine circovirus type 2. J Virol Methods 2011, 171(January (1)):26-33.
22. Krakowka S., Ellis J.A., McNeilly F., Ringler S., Rings D.M., Allan G. Activation of the immune system is the pivotal event in the production of wasting disease in pigs infected with porcine circovirus-2 (PCV-2). Vet Pathol 2001, 38(January (1)):31-42.
23. Feder I., Nietfeld J.C., Galland J., Yeary T., Sargeant J.M., Oberst R., et al. Comparison of cultivation and PCR-hybridization for detection of Salmonella in porcine fecal and water samples. J Clin Microbiol 2001, 39(July (7)):2477-2484.
24. Wisselink H.J., Reek F.H., Vecht U., Stockhofe-Zurwieden N., Smits M.A., Smith H.E. Detection of virulent strains of Streptococcus suis type 2 and highly virulent strains of Streptococcus suis type 1 in tonsillar specimens of pigs by PCR. Vet Microbiol 1999, 67(June (2)):143-157.
25. Hoelzle L.E., Adelt D., Hoelzle K., Heinritzi K., Wittenbrink M.M. Development of a diagnostic PCR assay based on novel DNA sequences for the detection of Mycoplasma suis (Eperythrozoon suis) in porcine blood. Vet Microbiol 2003, 93(May (3)):185-196.
26. Oliveira S., Galina L., Pijoan C. Development of a PCR test to diagnose Haemophilus parasuis infections. J Vet Diagn Invest 2001, 13(November (6)):495-501.
27. Song D.S., Kang B.K., Oh J.S., Ha G.W., Yang J.S., Moon H.J., et al. Multiplex reverse transcription-PCR for rapid differential detection of porcine epidemic diarrhea virus, transmissible gastroenteritis virus, and porcine group A rotavirus. J Vet Diagn Invest 2006, 18(May (3)):278-281.
28. Suarez P., Zardoya R., Prieto C., Solana A., Tabares E., Bautista J.M., et al. Direct detection of the porcine reproductive and respiratory syndrome (PRRS) virus by reverse polymerase chain reaction (RT-PCR). Arch Virol 1994, 135(1-2):89-99.
29. Kim J., Chae C. A comparison of virus isolation, polymerase chain reaction, immunohistochemistry, and in situ hybridization for the detection of porcine circovirus 2 and porcine parvovirus in experimentally and naturally coinfected pigs. J Vet Diagn Invest 2004, 16(January (1)):45-50.
30. Opriessnig T., Meng X.J., Halbur P.G. Porcine circovirus type 2 associated disease: update on current terminology, clinical manifestations, pathogenesis, diagnosis, and intervention strategies. J Vet Diagn Invest 2007, 19(November (6)):591-615.
31. Salminen S., von Wright A., Morelli L., Marteau P., Brassart D., de Vos W.M., et al. Demonstration of safety of probiotics - a review. Int J Food Microbiol 1998, 44(October (1-2)):93-106.
32. Hu S., Kong J., Kong W., Guo T., Ji M. Characterization of a novel LysM domain from Lactobacillus fermentum bacteriophage endolysin and its use as an anchor to display heterologous proteins on the surfaces of lactic acid bacteria. Appl Environ Microbiol 2010, 76(April (8)):2410-2418.
33. Trundova M., Celer V. Expression of porcine circovirus 2 ORF2 gene requires codon optimized E. coli cells. Virus Genes 2007, 34(April (2)):199-204.
34. Liu Q., Tikoo S.K., Babiuk L.A. Nuclear localization of the ORF2 protein encoded by porcine circovirus type 2. Virology 2001, 285(June (1)):91-99.
35. Khayat R., Brunn N., Speir J.A., Hardham J.M., Ankenbauer R.G., Schneemann A., et al. The 2.3-angstrom structure of porcine circovirus 2. J Virol 2011, 85(August (15)):7856-7862.
36. Zhou J.Y., Shang S.B., Gong H., Chen Q.X., Wu J.X., Shen H.G., et al. In vitro expression, monoclonal antibody and bioactivity for capsid protein of porcine circovirus type II without nuclear localization signal. J Biotechnol 2005, 118(August (2)):201-211.
37. Saluja V., Visser M.R., Ter Veer W., van Roosmalen M.L., Leenhouts K., Hinrichs W.L., et al. Influenza antigen-sparing by immune stimulation with gram-positive enhancer matrix (GEM) particles. Vaccine 2010, 28(November (50)):7963-7969.
38. Brull F., Mensink R.P., van den Hurk K., Duijvestijn A., Plat J. TLR2 activation is essential to induce a Th1 shift in human peripheral blood mononuclear cells by plant stanols and plant sterols. J Biol Chem 2010, 285(January (5)):2951-2958.
39. Shen H.G., Beach N.M., Huang Y.W., Halbur P.G., Meng X.J., Opriessnig T. Comparison of commercial and experimental porcine circovirus type 2 (PCV2) vaccines using a triple challenge with PCV2, porcine reproductive and respiratory syndrome virus (PRRSV), and porcine parvovirus (PPV). Vaccine 2010, 28(August (37)):5960-5966.
40. Ramamoorthy S., Opriessnig T., Pal N., Huang F.F., Meng X.J. Effect of an interferon-stimulated response element (ISRE) mutant of porcine circovirus type 2 (PCV2) on PCV2-induced pathological lesions in a porcine reproductive and respiratory syndrome virus (PRRSV) co-infection model. Vet Microbiol 2011, 147(January (1-2)):49-58.
41. Andersson M., Ahlberg V., Jensen-Waern M., Fossum C. Intestinal gene expression in pigs experimentally co-infected with PCV2 and PPV. Vet Immunol Immunopathol 2011, 142(July (1-2)):72-80.
42. Dias A.S., Gerber P.F., Araujo A.S., Auler P.A., Gallinari G.C., Lobato Z.I. Lack of antibody protection against porcine circovirus 2 and porcine parvovirus in naturally infected dams and their offspring. Res Vet Sci 2013, 94(April (2)):341-345.